Glycophos, Konzentrat zur Herstellung einer Infusionslösung

7680527800012 CH-52780 Konzentrat
Glycophos, Konzentrat zur Herstellung einer Infusionslösung
Glycophos, Konzentrat zur Herstellung einer Infusionslösung
Glycophos, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
20 x 20
Selling units
20
Measure
ml
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
29/07/2025
Summary of Product Characteristics
Français
29/07/2025
Summary of Product Characteristics
Italien
29/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
216.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
1.0 MMOL Substance Wirkstoff (Principe actif)
(N/A)
2.0 MMOL Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Fresenius Kabi (Schweiz) AG

6010 Kriens

Authorization information

Swissmedic authorization number
52780
Drug name
Glycophos, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
B05XA14
Authorization status
Z
Dispensing category
B
First authorization
23/02/1995
Authorization expiration date
31/12/9999
IT Number
07.01.2.
Domain
Human medicine
Field of application
Phosphat-Infusionszusatz

Package details

Description (FR)
GLYCOPHOS sol perf 20 amp 20 ml
Description (DE)
GLYCOPHOS Inf Lös 20 Amp 20 ml
Market launch
23/02/1995
Narcotic (BTM)
No

Other package sizes (1)

GLYCOPHOS sol perf 10 amp 20 ml
None None
GTIN: 7680527800128
Not in V1